Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports

Eli Lilly and Company's logo is displayed during a press conference in Houston, Texas, U.S., September 23, 2025. REUTERS/Antranik Tavitian/File Photo Purchase Licensing Rights, opens new tab March 30 (Reuters) - Eli Lilly (LLY.N), opens new tabwants the UK to regularly raise NHS drug prices and phase out a multi-billion-pound rebate scheme if it is to resume investment, its international businesses president Patrik Jonsson told the Financial Times. Eli Lilly seeks higher NHS drug prices, rebate overhaul to ...